MARCKS and cancer: Beyond its putative involvement in cancer pathogenesis, LINC01268 (also known as lnc-MARCKS or ROCKI) acts as a master regulator of inflammatory response in macrophages, inducing pro-inflammatory cytokines and chemokines by acting in cis on MARCKS promoter [57].